{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:34:49Z","timestamp":1785465289742,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Theme-based Research Scheme","award":["T11-705\/14N"],"award-info":[{"award-number":["T11-705\/14N"]}]},{"name":"General Research Fund","award":["HKU 780113M"],"award-info":[{"award-number":["HKU 780113M"]}]},{"name":"General Research Fund","award":["17121214"],"award-info":[{"award-number":["17121214"]}]},{"name":"General Research Fund","award":["17115015"],"award-info":[{"award-number":["17115015"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jaut.2016.10.006","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T14:00:25Z","timestamp":1477576825000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system"],"prefix":"10.1016","volume":"77","author":[{"given":"Qingyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.10.006_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib2","first-page":"2033","article-title":"Epidemiology of multiple sclerosis: results from a large observational study in the UK","volume":"262","author":"Jick","year":"2015","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jaut.2016.10.006_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI200113032","article-title":"A\u00a0virus-induced molecular mimicry model of multiple sclerosis","volume":"108","author":"Olson","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2016.10.006_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/1352458510394397","article-title":"Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence","volume":"17","author":"Oikonen","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2016.10.006_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jnnp.64.6.736","article-title":"Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis","volume":"64","author":"Edwards","year":"1998","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2016.10.006_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(98)00139-7","article-title":"Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis","volume":"159","author":"De Keyser","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jaut.2016.10.006_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0165-5728(98)00187-8","article-title":"Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1","volume":"92","author":"Kennedy","year":"1998","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib8","first-page":"476","article-title":"Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte\/endothelial cell adhesion during the initial stages of autoimmune demyelination","volume":"63","author":"Raine","year":"1990","journal-title":"Laboratory Invest. A J. Tech. Methods Pathology"},{"key":"10.1016\/j.jaut.2016.10.006_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.193.6.713","article-title":"Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis","volume":"193","author":"Huang","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.10.006_bib10","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.10.006_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.2000.01334.x","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions","volume":"122","author":"Boven","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"Sorensen","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2016.10.006_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jnr.10037","article-title":"Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis","volume":"66","author":"Fife","year":"2001","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jaut.2016.10.006_bib14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4049\/jimmunol.161.6.2667","article-title":"Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis","volume":"161","author":"Karpus","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib15","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.176.7.4399","article-title":"Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-\/- mice with experimental autoimmune encephalomyelitis","volume":"176","author":"Liu","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0165-5728(99)00166-6","article-title":"CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis","volume":"102","author":"Sellebjerg","year":"2000","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0165-5728(00)00397-0","article-title":"Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta","volume":"112","author":"Zang","year":"2001","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fncel.2014.00187","article-title":"Chemokine receptor expression by inflammatory T cells in EAE","volume":"8","author":"Mony","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2016.10.006_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-065X.2000.17717.x","article-title":"Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression","volume":"177","author":"Sallusto","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.10.006_bib20","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/eji.200939814","article-title":"Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN","volume":"39","author":"Steinman","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib21","first-page":"417","article-title":"Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study","volume":"240","author":"Andersen","year":"1993","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jaut.2016.10.006_bib22","first-page":"19","article-title":"Association of influenza incidence with multiple sclerosis onset. Folia neuropathologica\/association of polish neuropathologists and medical research centre","volume":"42","author":"Kazmierski","year":"2004","journal-title":"Pol. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.10.006_bib23","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.54.12.2307","article-title":"Multiple sclerosis and antecedent infections: a case-control study","volume":"54","author":"Marrie","year":"2000","journal-title":"Neurology"},{"issue":"Suppl","key":"10.1016\/j.jaut.2016.10.006_bib24","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ana.410360709","article-title":"Influence of infection on exacerbations of multiple sclerosis","volume":"36","author":"Panitch","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.10.006_bib25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20110226","article-title":"The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice","volume":"208","author":"Tu","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.10.006_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease","volume":"26","author":"Xiang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2016.10.006_bib27","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.4049\/jimmunol.1004043","volume":"186","author":"Guan","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.immuni.2009.10.011","article-title":"CD44 regulates survival and memory development in Th1 cells","volume":"32","author":"Baaten","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.10.006_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T\u00a0cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.10.006_bib30","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1476-5381.2009.00528.x","article-title":"The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function","volume":"158","author":"Ni","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2016.10.006_bib31","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S","article-title":"A\u00a0non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses","volume":"32","author":"Yang","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2016.10.006_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(85)90318-6","article-title":"Clinical viral infections and multiple sclerosis","volume":"2","author":"Morris","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2016.10.006_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jnen\/61.1.23","article-title":"Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis","volume":"61","author":"Wujek","year":"2002","journal-title":"J.\u00a0Neuropathology Exp. Neurology"},{"key":"10.1016\/j.jaut.2016.10.006_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","article-title":"Pathogenesis of tissue injury in MS lesions","volume":"98","author":"Trapp","year":"1999","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.smim.2004.02.004","article-title":"CD4 T cell responses to influenza infection","volume":"16","author":"Brown","year":"2004","journal-title":"Seminars Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jaut.2016.10.006_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/vim.2013.0004","article-title":"IFNgamma influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease","volume":"26","author":"Bowen","year":"2013","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mcne.1998.0725","article-title":"Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE","volume":"12","author":"Renno","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2016.10.006_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-5728(88)90137-3","article-title":"Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis","volume":"18","author":"Brosnan","year":"1988","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","article-title":"Tumor necrosis factor mediates myelin and oligodendrocyte damage in\u00a0vitro","volume":"23","author":"Selmaj","year":"1988","journal-title":"Ann. Neurology"},{"key":"10.1016\/j.jaut.2016.10.006_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine receptors: multifaceted therapeutic targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib43","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.162.3.1278","article-title":"Selective expression of a novel surface molecule by human Th2 cells in\u00a0vivo","volume":"162","author":"Nagata","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.10.006_bib44","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.1202026","article-title":"CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis","volume":"189","author":"Sato","year":"2012","journal-title":"J.\u00a0Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:08Z","timestamp":1760256908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116302499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":44,"alternative-id":["S0896841116302499"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.10.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}